SCHEMBL2157129

SCHEMBL2157129

CC(=O)Oc1cccc2c1c(C(=O)C(N)=O)c(C1CC1)n2Cc1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 19/20 0.75
PLA2G1B P04054 6/20 0.55
PLA2G10 O15496 4/20 0.55
PLA2G2E Q9NZK7 4/20 0.55
PLA2G5 P39877 3/20 0.55
PLA2G2F Q9BZM2 3/20 0.53
PLA2G2D Q9UNK4 3/20 0.53
PLA2G6 O60733 1/20 0.53
PLA2G2C Q5R387 1/20 0.53
PLA2G12B Q9BX93 1/20 0.53
PLA2G12A Q9BZM1 1/20 0.53
PLA2G3 Q9NZ20 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL819048 0.86 PLA2G2A (1.00) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
Acetic Acid Methyl Ester SCHEMBL27805118 0.85 PLA2G2A (0.66) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL819235 0.85 PLA2G2A (0.82) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL2157506 0.84 PLA2G2A (0.80) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL2157246 0.82 PLA2G2A (0.80) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL7112890 0.82 PLA2G2A (0.79) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL8502127 0.81 PLA2G2A (0.68) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL8503343 0.81 PLA2G2A (0.66) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL7717105 0.80 PLA2G2A (0.50) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL8503346 0.79 PLA2G2A (0.62) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0977566-A1 METHOD FOR THE TREATMENT OF STROKE USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS SHIONOGI & CO., LTD. (JP) 2000-02-09 EP claimed
WO-1998047508-A1 METHOD FOR THE TREATMENT OF STROKE USING N-HETEROCYCLIC GLYOXYLAMIDE COMPOUNDS SHIONOGI & CO., LTD. (JP) 1998-10-29 WO claimed
EP-2341045-A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid (acyloxy)alkyl or ((alkoxycarbonyl)oxy)alkyl ester as SPLA2 inhibitor Eli Lilly and Company (US) 2011-07-06 EP disclosed
US-5919810-A SEPTIC SHOCK ELI LILLY AND COMPANY (US) 1999-07-06 US disclosed
US-5919943-A INHIBITION OF SPLA2 ELI LILLY AND COMPANY (US) 1999-07-06 US disclosed
US-5733923-A SECRETORY PANCREATIC PHOSPHOLIPASE A2 ELI LILLY AND COMPANY (US) 1998-03-31 US disclosed